Association of 3.0-T brain magnetic resonance imaging biomarkers with cognitive function in the Dallas Heart Study.

IMPORTANCE Understanding the relationships between age-related changes in brain structure and cognitive function has been limited by inconsistent methods for assessing brain imaging, small sample sizes, and racially/ethnically homogeneous cohorts with biased selection based on risk factors. These limitations have prevented the generalizability of results from brain morphology studies. OBJECTIVE To determine the association of 3.0-T structural brain magnetic resonance (MR) imaging measurements with cognitive function in the multiracial/multiethnic, population-based Dallas Heart Study. DESIGN, SETTING, AND PARTICIPANTS Whole-brain, 2-dimensional, fluid-attenuated inversion recovery and 3-dimensional, magnetization-prepared, rapid acquisition with gradient echo MR imaging at 3.0 T was performed in 1645 Dallas Heart Study participants (mean [SD] age, 49.9 [10.5] years; age range, 19-85 years) who received both brain MR imaging and cognitive screening with the Montreal Cognitive Assessment between September 18, 2007, and December 28, 2009. Measurements were obtained for white matter hyperintensity volume, total brain volume, gray matter volume, white matter volume, cerebrospinal fluid volume, and hippocampal volume. Linear regression and a best predictive model were developed to determine the association of MR imaging biomarkers with the Montreal Cognitive Assessment total score and domain-specific questions. MAIN OUTCOMES AND MEASURES High-resolution anatomical MR imaging was used to quantify brain volumes. Scores on the screening Montreal Cognitive Assessment were used for cognitive assessment in participants. RESULTS After adjustment for demographic variables, total brain volume (P < .0001, standardized estimate [SE] = .1069), gray matter volume (P < .0001, SE = .1156), white matter volume (P = .008, SE = .0687), cerebrospinal fluid volume (P = .012, SE = -.0667), and hippocampal volume (P < .0001) were significantly associated with cognitive performance. A best predictive model identified gray matter volume (P < .001, SE = .0021), cerebrospinal fluid volume (P = .01, SE = .0024), and hippocampal volume (P = .004, SE = .1017) as 3 brain MR imaging biomarkers significantly associated with the Montreal Cognitive Assessment total score. Questions specific to the visuospatial domain were associated with the most brain MR imaging biomarkers (total brain volume, gray matter volume, white matter volume, cerebrospinal fluid volume, and hippocampal volume), while questions specific to the orientation domain were associated with the least brain MR imaging biomarkers (only hippocampal volume). CONCLUSIONS AND RELEVANCE Brain MR imaging volumes, including total brain volume, gray matter volume, cerebrospinal fluid volume, and hippocampal volume, were independently associated with cognitive function and may be important early biomarkers of risk for cognitive insult in a young multiracial/multiethnic population. A best predictive model indicated that a combination of multiple neuroimaging biomarkers may be more effective than a single brain MR imaging volume measurement.

[1]  Mark W. Woolrich,et al.  Advances in functional and structural MR image analysis and implementation as FSL , 2004, NeuroImage.

[2]  Jing He,et al.  Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phase. , 2010, Archives of neurology.

[3]  J M Wardlaw,et al.  Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study: the Rotterdam Scan Study , 2001, Journal of neurology, neurosurgery, and psychiatry.

[4]  Charles DeCarli,et al.  Stroke Risk Profile Predicts White Matter Hyperintensity Volume: The Framingham Study , 2004, Stroke.

[5]  N. Schuff,et al.  Longitudinal volumetric MRI change and rate of cognitive decline , 2005, Neurology.

[6]  M. Weiner,et al.  Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample , 2011, Neurology.

[7]  D. Harvey,et al.  Anatomical Mapping of White Matter Hyperintensities (WMH): Exploring the Relationships Between Periventricular WMH, Deep WMH, and Total WMH Burden , 2005, Stroke.

[8]  P. Matthews,et al.  White matter lesion progression, brain atrophy, and cognitive decline: The Austrian stroke prevention study , 2005, Annals of neurology.

[9]  S. Black,et al.  Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[10]  B L Miller,et al.  Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. , 2001, Archives of neurology.

[11]  K. Walhovd,et al.  Structural Brain Changes in Aging: Courses, Causes and Cognitive Consequences , 2010, Reviews in the neurosciences.

[12]  O. Lopez,et al.  Cerebral Infarcts and Cognitive Performance: Importance of Location and Number of Infarcts , 2009, Stroke.

[13]  N. Risch,et al.  The importance of race and ethnic background in biomedical research and clinical practice. , 2003, The New England journal of medicine.

[14]  F. Fazekas,et al.  Pathologic correlates of incidental MRI white matter signal hyperintensities , 1993, Neurology.

[15]  Ronald M Peshock,et al.  The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. , 2004, The American journal of cardiology.

[16]  C. DeCarli,et al.  Imaging of static brain lesions in vascular dementia: implications for clinical trials. , 1999, Alzheimer disease and associated disorders.

[17]  M. Caldwell,et al.  American Heart Association: Council on Cardiovascular Nursing , 2004, The Journal of cardiovascular nursing.

[18]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[19]  D. Harvey,et al.  Measures of brain morphology and infarction in the framingham heart study: establishing what is normal , 2005, Neurobiology of Aging.

[20]  P. Wolf,et al.  White Matter Hyperintensity and Cognitive Functioning in the Racial and Ethnic Minority Cohort of the Framingham Heart Study , 2010, Neuroepidemiology.

[21]  Marwan N. Sabbagh,et al.  The Montreal Cognitive Assessment and the Mini-Mental State Examination as Screening Instruments for Cognitive Impairment: Item Analyses and Threshold Scores , 2011, Dementia and Geriatric Cognitive Disorders.

[22]  Ronald M Peshock,et al.  Automated quantification of white matter disease extent at 3 T: Comparison with volumetric readings , 2012, Journal of magnetic resonance imaging : JMRI.

[23]  C. DeCarli,et al.  Subclinical cerebrovascular disease in mild cognitive impairment , 2009, Neurology.

[24]  Lewis H. Kuller,et al.  White matter grade and ventricular volume on brain MRI as markers of longevity in the cardiovascular health study , 2007, Neurobiology of Aging.

[25]  A. Folsom,et al.  Cerebral MRI findings and cognitive functioning , 2005, Neurology.

[26]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[27]  D. Bennett,et al.  The association of magnetic resonance imaging measures with cognitive function in a biracial population sample. , 2010, Archives of neurology.

[28]  E. Akbudak,et al.  Neuroimaging signatures and cognitive correlates of the montreal cognitive assessment screen in a nonclinical elderly sample. , 2011, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[29]  H. Markus,et al.  The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[30]  H. Markus,et al.  Magnetic Resonance Imaging in Cerebral Small Vessel Disease and its Use as a Surrogate Disease Marker , 2011, International journal of stroke : official journal of the International Stroke Society.

[31]  Wiro J Niessen,et al.  A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline. , 2010, Brain : a journal of neurology.

[32]  Charles DeCarli,et al.  MRI predictors of cognitive change in a diverse and carefully characterized elderly population , 2012, Neurobiology of Aging.

[33]  A. Brickman,et al.  Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. , 2008, Archives of neurology.

[34]  Eric E. Smith,et al.  Leukoaraiosis and Stroke , 2010, Stroke.

[35]  C. Klein,et al.  VALIDITY OF THE MoCA AND MMSE IN THE DETECTION OF MCI AND DEMENTIA IN PARKINSON DISEASE , 2010, Neurology.

[36]  E. Rostrup,et al.  Decline in intelligence is associated with progression in white matter hyperintensity volume , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[37]  D. Loewenstein,et al.  Association of White Matter Hyperintensity Measurements on Brain MR Imaging with Cognitive Status, Medial Temporal Atrophy, and Cardiovascular Risk Factors , 2009, American Journal of Neuroradiology.

[38]  Mark W. Woolrich,et al.  Bayesian analysis of neuroimaging data in FSL , 2009, NeuroImage.

[39]  A. Khera,et al.  Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. , 2004, Journal of the American College of Cardiology.

[40]  R. D'Agostino,et al.  Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. , 2006, Archives of neurology.